In two letters to Capitol Hill leaders, ICMAD supported the Cosmetic Modernization Amendments of 2015 (HR 4075), which will foster continued Food and Drug Administration (FDA) oversight and ensure the cosmetic industry’s long record of prioritizing safety. The bill, sponsored by Representative Pete Sessions, will also prevent artificial barriers to entry to the marketplace or unnecessary burdens that will stifle the innovation and growth of small businesses.
At a recent Senate Health Education Labor and Pensions (HELP) Committee hearing, Curran Dandurand, president and CEO of Jack Black and an ICMAD member, testified about the massive burden placed on small businesses forced to comply with a patchwork of state regulations, and urged Congress to implement a national safety standard. ICMAD president and CEO Pam Busiek wrote to HELP Committee chairman Lamar Alexander (R-TN) and ranking member Patty Murray (D-WA) that modernizing cosmetic regulations is essential. She said a national safety standard is necessary to establish uniform, science-based guidelines that apply equally to all states.
“While ICMAD supports modernization of the FDA laws governing cosmetics, the methods proposed by the Feinstein-Collins bill in achieving this objective are problematic for the small businesses ICMAD represents,” Busiek commented. “Although the Feinstein-Collins bill is well-intentioned, it would ultimately do more harm than good in the name of promoting safety.”
ICMAD also expressed concerns about a legislation discussion draft House Energy and Commerce Committee ranking member Frank Pallone (D-NJ) and representative Leonard Lance (R-NJ) released last month. In comments submitted to the Committee, ICMAD warned that the current discussion draft fails to establish a national safety standard, threatens to overburden small businesses and increases costs, which will negatively affect businesses and consumers.